• This record comes from PubMed

Editorial: Probiotic bacteria-derived effector molecules and their impact on the host in health and disease

. 2022 ; 13 () : 1089461. [epub] 20221129

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection

Document type Editorial

Comment On

Editorial on the Research Topic Probiotic bacteria-derived effector molecules and their impact on the host in health and disease PubMed

See more in PubMed

Lebeer S., Bron P. A., Marco M. L., Van Pijkeren J. P., O'Connell Motherway M., Hiil C., et al. . (2018). Identification of probiotic effector molecules: present state and future perspectives. Curr. Opin. Biotechnol. 49, 217–223. 10.1016/j.copbio.2017.10.007 PubMed DOI

Pyclik M., Srutkova D., Schwarzer M., Gorska S. (2020). Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids, and proteins - their chemical structure and biological attributes. Int. J. Biol. Macromol. 147, 333–349. 10.1016/j.ijbiomac.2019.12.227 PubMed DOI

Tlaskalova-Hogenova H., Stěpánková R., Kozáková H., Hudcovic T., Vannucci L., Tučková L., et al. . (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8, 110–120. 10.1038/cmi.2010.67 PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...